SAN CLEMENTE, Calif. (AP) _ Glaukos Corp. (GKOS) on Wednesday reported a loss of $16.5 million in its first quarter.

On a per-share basis, the San Clemente, California-based company said it had a loss of 36 cents. Losses, adjusted for amortization costs and costs related to mergers and acquisitions, were 21 cents per share.

The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 30 cents per share.

The glaucoma treatments developer posted revenue of $68 million in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $64.8 million.

For the current quarter ending in July, Glaukos said it expects revenue in the range of $70 million to $72 million.

Glaukos shares have climbed 20% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $90.44, more than doubling in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GKOS at https://www.zacks.com/ap/GKOS

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News